Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

astrazeneca_building_white

AstraZeneca to pit blood cancer drug Calquence against COVID-19 with the company’s fastest-ever trial launch

April 14, 2020
Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Calquence, coronavirus, pharma

As the R&D race against COVID-19 continues, AstraZeneca is poised to launch a global, multicentre clinical trial to test its …

News
gilead-sciences

Gilead’s promising COVID-19 drug remdesivir shows benefit in 68% of hospitalised patients

April 14, 2020
Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead has provided an update on its ongoing efforts against the novel coronavirus, revealing data from a cohort analysis of …

News
shutterstock_138095450

Circassia terminates AstraZeneca partnership in exchange for £150m debt settlement

April 9, 2020
Sales and Marketing AstraZeneca, Circassia, partnership, pharma, respiratory

Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …

News
shutterstock_273326141

Roche signs multi-billion dollar RNA-targeted drug discovery deal with Arrakis Therapeutics

April 9, 2020
Research and Development, Sales and Marketing Arrakis, Roche, partnership, pharma

Roche has signed a new partnership with Arrakis Therapeutics in a bid to drive discovery of RNA-targeted small molecule (rSM) …

News
90ten_team_photo

Envision Pharma Group acquires healthcare comms consultancy 90TEN

April 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90TEN, Envision Pharma Group, pharma

Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, it has been revealed. 90TEN said that it …

News
sage_logo

Sage Therapeutics to halve its total workforce in radical cost-cutting move

April 8, 2020
Research and Development, Sales and Marketing Sage Therapeutics, pharma, staff cuts

Sage Therapeutics has revealed a radical restructuring effort to cut costs and “enable the company to advance its corporate strategy …

News
partnership

Second Genome to help drive development of Gilead therapies in potential $1.5bn deal

April 8, 2020
Research and Development Gilead, Second Genome, pharma

Gilead and microbiome science specialist Second Genome have announced they are to partner up to advance a selection of the …

News
takeda_usa_pharmaceuticals_u

Takeda’s Alunbrig outclasses Xalkori to secure EU approval in ALK+ advanced non-small cell lung cancer

April 7, 2020
Manufacturing and Production, Sales and Marketing Alunbrig, Europe, Takeda, pharma

The European Commission has ruled to expand the current approved indication of Takeda’s Alunbrig (brigatinib), authorising the drug as a …

News
fda2outsideweb

FDA approval for BMS and Acceleron’s Reblozyl to reduce red blood cell transfusion dependence

April 6, 2020
Manufacturing and Production, Sales and Marketing BMS, FDA, Reblozyl, pharma

The FDA has given the regulatory thumbs-up in the US of Reblozyl (luspatercept-aamt), the “first and only erythroid maturation agent” …

News
novo_nordisk_flag

European approval for Novo’s Rybelsus to control blood sugar in type 2 diabetes

April 6, 2020
Sales and Marketing Novo Nordisk, Rybelsus, diabetes, pharma

The European Commission has greenlighted Novo Nordisk’s Rybelsus (oral semaglutide) as an adjunct to diet and exercise to improve glycaemic …

News
david_setboun

Industry veteran Dr David Setboun joins BrainStorm as Executive VP and COO

April 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BrainStorm Therapeutics, appointments, pharma

BrainStorm Cell Therapeutics, a firm developing cellular therapies to tackle neurodegenerative diseases, has named industry Big Pharma veteran Dr David …

Appointment
alimera_sciences_logo

Steven T Gill returns to Alimera as VP, Thought Leader Engagement

April 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alimera Sciences, Novartis, pharma

Ophthalmology specialist Alimera Sciences has announced that Steven T Gill is to return to the company in the newly created …

Appointment
merckwindow_web

MSD’s Keytruda hits Phase 3 main goal in first-line colorectal cancer sub-population

April 3, 2020
Medical Communications, Research and Development MSD, colorectal cancer, keytruda, pharma

MSD has lifted the veil on new Phase 3 for its blockbuster immunotherapy Keytruda, showing that the anti-PD-1 therapy met …

News

Sanofi and Regeneron’s Dupixent combo impresses in paediatric atopic dermatitis

April 3, 2020
Medical Communications, Research and Development Dupixent, Sanofi, atopic dermatitis, pharma

Sanofi and Regeneron have unveiled new Phase 3 data for their IL-4 and IL-13 inhibitor Dupixent (dupilumab), showing strong results …

News
blood-75301_1280

US approval for haemophilia drug derived from genetically engineered rabbit’s milk

April 2, 2020
Sales and Marketing FDA, US, haemophilia, pharma

The FDA has announced the approval of Sevenfact, a haemophilia therapy the active ingredient from which is expressed in genetically …

News
The Gateway to Local Adoption Series

Latest content

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026